“Additionally, medium, and high doses of API significantly reduced the potentiation of estradiol on ER expression, attenuated the transmission of estrogen/ER signaling, thereby inhibiting the phosphorylation of ERK1/2 and JNK1/2/3 in the MAPK.”
“Besides, we found that API competitively bound to ER with estradiol , and showed a weak selectivity to ERβ.”
“In vivo data indicated that API treatment significantly inhibited the enhancement of estradiol on clinical symptoms.”